MOWOOT Device Treatment for Adults with Chronic Constipation

Last updated: December 12, 2024
Sponsor: usMIMA S.L.
Overall Status: Active - Recruiting

Phase

N/A

Condition

Gastrointestinal Diseases And Disorders

Lactose Intolerance

Colic

Treatment

Intermittent Colonic Exoperistalsis with MOWOOT device

Standard of care with Trans-Anal Irrigation

Clinical Study ID

NCT04666155
MOW-06-2023
  • Ages 18-99
  • All Genders

Study Summary

The primary objective is to compare the effectiveness of the experimental Intermittent Colonic Exoperistalsis (ICE) treatment with MOWOOT, with the active control of trans-anal irrigation (TAI) as standard-of-care. The secondary objectives are to further compare the ICE treatment with MOWOOT to the TAI standard-of-care clinically and economically.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Any gender 18 years or older

  2. Symptoms meeting the American College of Gastroenterology definition of chronicconstipation: unsatisfactory defaecation characterized by infrequent stool,difficult stool passage or both for at least previous 3 months

  3. Bothered by their constipation

  4. PAC-QOL ≥1.8

  5. Using TAI for at least 3 months

  6. Able to undertake the treatment with TAI or with the device themselves or with acarer willing to do it

  7. Able to understand the study requirements

  8. Able to understand written and spoken English (due to questionnaire validity)

  9. Able and willing to provide written informed consent to participate

Exclusion

Exclusion Criteria:

Disease phenotype exclusion criteria:

  1. Irritable Bowel Syndrome with Diarrhoea (IBS-D) or alternating constipation anddiarrhoea (IBSmix): (not due to laxative use)

  2. Inflammatory Bowel Disease (IBD) Device-related exclusion criteria:

  3. Abdominal perimeter ≤65cm or ≥130cm

  4. Unable to independently use the MOWOOT or TAI technology, unless a carer isavailable daily to assist Other medical conditions, medications and contraindications:

  5. Previous large bowel resection

  6. The presence of a stoma

  7. External rectal prolapse

  8. Active anorexia or bulimia

  9. Active abdominal cancer

  10. Large inguinal or umbilical hernia

  11. Recent abdominal scars, abdominal wounds or skin disorders that may make abdominalmassage uncomfortable

  12. Pregnancy or attempt to become pregnant in the next 6 months

  13. Use of strong opioids*

  14. Use of antidepressants, bladder stabilisers or any other medication inducing, ortreating, constipation unless used at a stable dose for at least 4 weeks beforeScreening Visit (this excludes laxatives which may be used as required up to threedays before the screening visit)

  15. Subjects already undertaking or have undertaken abdominal massage unless theyunderwent a previous washout period of at least 2 months

  16. Participation in another parallel interventional clinical trial or less than 2months from participation in a previous interventional clinical trial

  17. Planned surgery for constipation if it might be within trial dates

Study Design

Total Participants: 86
Treatment Group(s): 2
Primary Treatment: Intermittent Colonic Exoperistalsis with MOWOOT device
Phase:
Study Start date:
April 25, 2024
Estimated Completion Date:
May 25, 2025

Study Description

The RCT will assess clinical effectiveness by means of quantitative and qualitative variables, and the cost effectiveness by means of economic outcomes.

Connect with a study center

  • University Hospital of North Durham, NHS Foundation Trust

    Durham, County Durham and Darlington DH5TW
    United Kingdom

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.